Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Anxiety Disorders 2Weight Loss 1Recurrence 1Lung Neoplasms 1Glioma 1Fatigue 1Depression 1Colorectal Adenocarcinoma 1Carcinoma, Non-Small-Cell Lung 1Cachexia 1Brain Neoplasms 1Advanced Cancer 1Adenocarcinoma of Lung 1

Interventions

Cyclophosphamide 115Dexamethasone 70fludarabine phosphate 57Cytarabine 56fludarabine 52Rituximab 51Peripheral Blood Stem Cell Transplantation 40Etoposide 40Gemcitabine 39Lenalidomide 38pembrolizumab 33Radiotherapy 33Busulfan 33Filgrastim 32Carboplatin 31Methotrexate 30Cyclosporine 29Cisplatin 29Bortezomib 29Mycophenolic Acid 28Melphalan 28venetoclax 27Paclitaxel 26Whole-Body Irradiation 24Antilymphocyte Serum 23Temozolomide 22Granulocyte Colony-Stimulating Factor 20Calcium Dobesilate 20Bevacizumab 20Tacrolimus 19

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Recurrence × Fluoxetine × Clear all
NCT05634707 2025-09-22

Evaluation of Fluoxetine and Cytotoxic Lysosomal Stress in Glioma (FLIRT)

Duke University

Phase EARLY_PHASE1 Active not recruiting
10 enrolled
CNS

Brain Neoplasms, Glioma, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon âš¡